Comparison of the treatment effect between lenvatinib and atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in pathologically diagnosed metabolic dysfunction–associated steatotic liver disease.
| Autor: | Takahashi, Hirokazu, Koshiyama, Yuichi, Mitsumoto, Yasuhide, Kobayashi, Takashi, Hayashi, Hideki, Arai, Taeang, Sawada, Koji, Nonaka, Michihiro, Nakahara, Takashi, Tomita, Kengo, Ito, Takanori, Notsumata, Kazuo, Seko, Yuya, Fujii, Hideki, Aishima, Shinichi, Yoneda, Masato, Toyoda, Hidenori, Sumida, Yoshio, Nakajima, Atsushi, Okanoue, Takeshi |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p493-493, 151p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|